N-Hydroxy-7-(6-(4-(3-ethylureido)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-heptanamide

ID: ALA4469377

PubChem CID: 155533759

Max Phase: Preclinical

Molecular Formula: C25H34N8O4

Molecular Weight: 510.60

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(CCCCCCC(=O)NO)c3n2)cc1

Standard InChI:  InChI=1S/C25H34N8O4/c1-2-26-25(35)28-19-10-8-18(9-11-19)22-29-23(32-13-15-37-16-14-32)20-17-27-33(24(20)30-22)12-6-4-3-5-7-21(34)31-36/h8-11,17,36H,2-7,12-16H2,1H3,(H,31,34)(H2,26,28,35)

Standard InChI Key:  JVBTTYDAUQOZQB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
   17.1820  -12.5180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.7214  -11.2921    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7203  -12.1116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4283  -12.5206    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4265  -10.8832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4241  -10.0660    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.1308   -9.6622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1303   -8.8486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4232   -8.4382    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.7149   -8.8477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7137   -9.6675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1351  -11.2885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1399  -12.1071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9205  -12.3551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.3973  -11.6904    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9122  -11.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3445  -13.0537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1615  -13.0358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5855  -13.7344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4025  -13.7165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8265  -14.4151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6435  -14.3971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0365  -13.6806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8535  -13.6627    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.6125  -12.9821    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.0055  -12.2656    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.0122  -12.5196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3064  -12.1090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5989  -12.5164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5978  -13.3345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3102  -13.7435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0148  -13.3338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8903  -13.7434    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1824  -13.3352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4749  -13.7442    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7670  -13.3360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0595  -13.7450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 34  1  2  0
  2  3  2  0
  3  4  1  0
  4 13  2  0
 12  5  2  0
  5  2  1  0
  5  6  1  0
  6  7  1  0
  6 11  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 12  1  0
 14 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
  3 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 30 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4469377

    ---

Associated Targets(Human)

OCI-AML-3 (139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OCI-AML2 (350 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MM1.S (1111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Raji (5516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 510.60Molecular Weight (Monoisotopic): 510.2703AlogP: 2.93#Rotatable Bonds: 11
Polar Surface Area: 146.53Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.91CX Basic pKa: 3.71CX LogP: 2.70CX LogD: 2.69
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.17Np Likeness Score: -1.99

References

1. Chen Y, Yuan X, Zhang W, Tang M, Zheng L, Wang F, Yan W, Yang S, Wei Y, He J, Chen L..  (2019)  Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy.,  62  (3): [PMID:30629434] [10.1021/acs.jmedchem.8b01825]

Source